Transphorm, Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2023 12 months to Mar 31, 2023	FY2022 12 months to Mar 31, 2022	FY2021 12 months to Dec 31, 2020	FY2019 12 months to Jun 30, 2019	FY2018 12 months to Jun 30, 2018
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Inventory write-off
Provision for inventory
Depreciation and amortization
Licensing revenue from a related party
Provision for doubtful accounts
Amortization of right-of-use assets
Perpetual licensing revenue from a related party (Note 18)
Stock-based compensation
Interest cost
Gain on promissory note conversion
Gain on sale of equipment
Loss in joint venture
Changes in fair value of derivative instruments
Changes in fair value of promissory note
Changes in operating assets and liabilities:
Accounts receivable
Inventory
Prepaid expenses and other current assets
Other assets
Accounts payable and accrued expenses
Accounts payable, accrued expenses, and other liabilities
Deferred revenue
Accrued payroll and benefits
Operating lease liabilities
Net cash used in operating activities
Cash flows from investing activities:
Purchases of property and equipment
Proceeds from sale of equipment
Investment in joint venture
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from development loans
Proceeds from sale of equipment
Proceeds from stock option exercise
Proceeds from issuance of common stock
Cost associated with issuance of common stock
Payment for taxes related to net share settlement of restricted stock units
Loan repayment
Proceeds from exercise of warrants
Payment for repurchase of common stock
Net cash provided by financing activities
Net decrease in cash
Cash, beginning of year
Cash, end of year
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash
Net (decrease) increase in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of year
Cash, cash equivalents and restricted cash at end of year
Supplemental disclosures of cash flow information:
Interest expense paid
Supplemental non-cash investing activity:
Equipment purchases
Supplemental non-cash financing activity:
Issuance of shares in connection with a service contract
Operating lease right-of-use asset obtained in exchange for operating lease liabilities
Development loan reduction related to perpetual licensing revenue
Conversion of promissory note
Conversion of preferred stock to common stock in connection with the Reverse Merger
Private placement offering cost
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets
Cash and cash equivalents
Restricted cash

Comments